The Home Depot Data Breach Class Action has been conditionally settled.

To view the details of the settlement, please visit http://www.canadahomedepotdatabreachsettlement.com/

Please read the settlement notice: notice

Please read the settlement agreement.

Please read the conditional certification order to learn more: certification order 

.

Read Full Article

We are pleased to advise that a settlement has been reached and the case has now been certified by the Superior Court as a class action for the purpose of giving effect to the settlement. Final Court approval was obtained on August 15, 2014.

Read Full Article

In December Pfizer produced tens of thousands of documents, purportedly all the documents it is required to provide in this action.  We are in the process of reviewing those documents in detail.  Our initial review suggests that not all necessary documents have been produced.

In early January a case conference was conducted by the judge overseeing the lawsuit.  The judge set the date of June 5, 2014 to hear any motions needed in respect of the documents Pfizer has produced.

It is expected that examinations for discovery of a Pfizer representative and the representative plaintiff will be conducted.

A date for the common issue trial has not yet been set but it is presently expected to be held sometime in 2015.

Read Full Article

This is an update regarding the ongoing administration of the settlement of the Bextra and Celebrex class action. 

The settlement is administered by Collectiva Class Action Services based out of Montreal, QC. Collectiva has advised us that, as of last month, it had received a total of 433 claims for compensation regarding personal injuries. All but 5 of those claims were then sent by Collectiva to the adjudicators, who are the medical doctors who decide whether a claim is eligible for compensation. Of the remaining 428 claims, 354 have already been adjudicated, meaning that the doctors have made a determination about whether those claims are eligible for compensation or not. The adjudicators were still reviewing 82 claims. 

When an adjudicator makes a determination, Collectiva then delivers to the claimant, or to the law firm representing the claimant, a determination letter that describes and explains the adjudicator’s decision. If you have not yet received a determination letter, it is probably because the adjudicators are still considering your claim. If we are representing you in the settlement, then you should receive a determination letter from us within the next month or two.

Note that no settlement moneys will be distributed until every claim has been adjudicated. If the total value of all of the claims made exceeds the total amount contributed by the defendants, then every claim will be reduced on a pro rated basis. 

Read Full Article

McPhadden Samac Tuovi LLP is pleased to announce that a settlement of this class action has been reached with the Sony defendants.

Read Full Article

McPhadden Samac Tuovi LLP has commenced a class action against Sony Corporation and other Sony companies related to the theft from Sony of personal information of Playstation network and Qriocity service users.  The theft may also include user credit card information.

The action has been brought on behalf of all persons in Canada who used Sony’s online PlayStation network or Qriocity services up to May 2, 2011 and who provided Sony with personal and/or credit or debit card information.

For further information, to register with our firm, and to receive future information about this case (click here) 

For our media release (click here) 

Update (click here).

Read Full Article

McPhadden Samac Tuovi have commenced a proposed class action against Johnson & Johnson and related companies relative to the collagen dermal filler Evolence. The Evolence claim involves people who were injected with Evolence and allegedly developed side effects that in some cases included disfiguring nodule formation.

Media Release.

For further information and instructions.

Read Full Article

On behalf of two Mississauga, Ontario plaintiffs, McPhadden Samac Tuovi has commenced a proposed class action against GLAXOSMITHKLINE INC. and related companies ("GSK") relative to the drug Rosiglitazone which is widely used to lower blood sugar levels in people who suffer from Type II diabetes mellitus.  Rosiglitazone is marketed and sold by DSK under the brand names Avandia™, Avandamet™, and Avandaryl™. 

For further information and instructions.

Read Full Article

A class action has been commenced in the Ontario Superior Court by MSMT on behalf of persons suffering damage as a consequence of the smoking cessation drug Champix (varenicline).

English language press release. 
A free online assessment is available.
 

Read Full Article